Download Brochure
Table of Content
Get a Price
April 2025
.webp)
Principal Consultant
Reviewed By
The U.S. dermatology market size is calculated at USD 514.58 million in 2024, grew to USD 552.15 million in 2025, and is projected to reach around USD 1041.01 million by 2034. The market is expanding at a CAGR of 7.3% between 2025 and 2034. The increasing prevalence of skin disorders, technological advancements, and favorable government policies drive the market.
Dermatology is a field of science that involves the study, research, diagnosis, and management of skin, hair, and nail disorders. Skin is the largest organ of the body, serving as a barrier to protect internal organs. Hence, the maintenance of good skin condition is essential to prevent severe chronic disorders. Dermatologists are medical professionals who diagnose and treat skin disorders. The different types of treatments available include medications (externally applied or injected), ultraviolet therapy, surgical procedures, and cosmetic procedures. Some of the common conditions that need treatment include acne, eczema, hair loss, nail fungus, psoriasis, and skin cancer.
The market is driven by several growth factors, including the rising prevalence of skin disorders and autoimmune disorders and the increasing geriatric population. The growing awareness about aesthetic skin and youthful appearance necessitates people to take care of their skin. Favorable government policies and increasing investment promote research and development activities to develop novel skincare products. The increasing collaborations and mergers & acquisitions promote the market. The rapidly expanding pharmaceutical and cosmetic sectors also potentiate market growth.
Artificial intelligence (AI) has the potential to transform the future of dermatology, driving the latest innovations. AI simplifies the task of researchers by introducing automation in the research process. It leads to the development of products with enhanced efficacy and reduced side effects. AI and machine learning (ML) algorithms have been proven to revolutionize the screening process for skin disorders. They also aid in early diagnosis of skin conditions, enabling dermatologists to make effective clinical decisions. Deep learning algorithms can recognize certain images of medical imaging. Additionally, AI can revolutionize patient care by predicting personalized therapies based on their conditions, enhancing treatment accuracy. AI and ML can also suggest potential implications of certain therapies, reducing adverse effects.
Growing Research and Development
The major growth factor of the U.S. dermatology market is the growing research and development activities. Several research institutions and pharmaceutical and cosmetic companies are conducting research to develop novel products. Novel pharmaceuticals are being investigated to treat severe, rare disorders and find extended applications of existing drugs. The growing demand for cell and gene therapy has revolutionized the skin treatment field. Regenerative medicines can shorten the healing process and accelerate the natural responses of the human organism for more effective skin regeneration. Apart from these, numerous other biologicals, such as monoclonal antibodies, are tested for their effectiveness against skin disorders. Additionally, advancements are made in screening and diagnoses of various skin disorders at an early stage. The increasing investments from various government and private organizations facilitate research and development.
Lack of Trained Professionals
The major challenge faced by the market is the lack of trained professionals or dermatologists. Only around 11,500 active dermatologists in the U.S. serve a population of 346 million. Such a shortage of dermatologists affects the advanced treatment of patients, especially patients living in underserved areas. Thus, the inadequacy of the dermatology physician workforce to meet the demand for dermatologic services in nonmetropolitan areas hinders the market.
3D Printing
The future of the U.S. dermatology market is promising, driven by advanced technologies such as telemedicine and 3D printing. Telemedicine allows dermatologists to diagnose and treat patients from remote areas. 3D printing is a technology for constructing 3D objects from a CAD model or a digital 3D model. It has been found to play an immense role in dermatology by manufacturing artificial skin. Artificial skin is a collagen scaffold that can be used for the treatment of burn injuries, skin disorders, and trauma. It is also used to test new cosmetic, chemical, and pharmaceutical products on animals. Numerous companies are focusing on developing artificial skin through 3D printing for various human and non-human applications. 3D printing offers superior benefits over conventional methods, such as reduced material waste, faster production, and enhanced reproducibility.
By product type, the cosmetic dermatology segment dominated the U.S. dermatology market in 2024. Cosmetic dermatology is a specialized field that involves maintaining beautiful and youthful skin. The growing demand for aesthetic appearance and technological advancements boost the segment’s growth. The availability of laser therapy, facial injectables, and photo facials simplifies the task of a cosmetic dermatologist. A cosmetic dermatologist helps patients address skin tone and texture irregularities, smooth wrinkles, remove unwanted facial or body hair, tighten skin, remove tattoos, and treat acne scars.
By product type, the surgical dermatology segment is anticipated to show lucrative growth in the U.S. dermatology market during the forecast period. The increasing number of plastic surgeries to enhance aesthetic appearance or treat skin disorders augments the segment’s growth. The U.S. conducts the highest number of plastic surgeries every year owing to the presence of skilled professionals and advanced technology. The U.S. performed more than 6.1 million plastic surgeries in 2023, according to the International Society of Aesthetic Plastic Surgery (ISAPS) report. Tumor removal, hand surgery, breast reconstruction, maxillofacial surgery, and scar revision were the top 5 procedures in 2023.
By application, the acne segment held the largest share of the U.S. dermatology market in 2024. The increasing prevalence of acne and growing awareness about acne treatment fuel the segment’s growth. American Academy of Dermatology estimates that acne affects around 50 million individuals in the U.S. annually. It is also estimated that around 80% of the U.S. population between 11 to 30 years will have at least a mild form of acne. The growing research and development activities lead to the invention of novel treatment regimens for acne, potentiating the segment’s growth.
By application, the dermatitis segment is expected to grow at the fastest rate in the U.S. dermatology market during the forecast period. Dermatitis is the second most common type of skin disorder, affecting around 10-15% of children and 7-10% of adults in the U.S. The rising prevalence of dermatitis and allergic reactions promotes the segment’s growth. The lack of an effective treatment regimen for dermatitis opens doors for many researchers to develop effective treatments with reduced side effects. Organizations like the Asthma and Allergy Foundation of America and the National Eczema Association support the development of novel therapeutics and promote R&D activities in the U.S.
By end-use, the skin clinics segment led the U.S. dermatology market in 2024. The presence of skilled professionals and the availability of specialized equipment contribute to the segment’s growth. Skin care clinics have suitable capital investment to adopt advanced technological products. The increasing number of skin clinics also favors the segment’s growth. There are around 4,965 skin clinics in the U.S. as of 2024.
The different growth factors positively impacting the U.S. market include the increasing geriatric population and favorable government policies. The number of Americans ages 65 and above is projected to reach to 82 million by 2050. The geriatric population is more prone to developing dermatological disorders due to their aging process. The increasing investments, collaborations, and mergers & acquisitions contribute to the market. The impact of private equity has shown tremendous growth in dermatology from a single key investor in 2011 to more than 35 by 2024. Favorable regulatory frameworks encourage key players to develop and launch novel products in the U.S. market. The U.S. Food and Drug Administration (FDA) approved a total of 7 new dermatologic therapies and expanded the indications of 7 marketed therapies in 2024.
Chris Riat, Global Neutrogena Brand Leader, commented on its collaboration with Dr. Dhaval Bhanusali and Dr. Muneeb Shah, the two most followed dermatologists worldwide, that the company aims to strengthen their leadership in dermatological beauty and deepen their connections with the healthcare professional community, retailers, and consumers.
By Product Type
By Application
By End-Use
April 2025
April 2025
March 2025
March 2025
Schedule a Meeting